MANKIND PHARMA
Back to All Ratios
|
MANKIND PHARMA Last 5 Year EV/Net Sales History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EV/Net Sales(x) | 6.19 | 8.82 | 8.92 | -0.03 | 0.06 |
What is the latest EV/Net Sales ratio of MANKIND PHARMA ?
| Year | EV/Net Sales |
|---|---|
| Mar2026 | 6.19 |
| Mar2025 | 8.82 |
| Mar2024 | 8.92 |
| Mar2023 | -0.03 |
| Mar2022 | 0.06 |
How is EV/Net Sales of MANKIND PHARMA Trending?
| Years | EV/Net Sales | % Change | |
|---|---|---|---|
| Mar2026 | 6.19 | -29.82 | |
| Mar2025 | 8.82 | -1.12 | |
| Mar2024 | 8.92 | Positive | |
| Mar2023 | -0.03 | Negative | |
| Mar2022 | 0.06 | - | |
Other Financial Ratios of MANKIND PHARMA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Net Sales ratio of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,572.7 Cr | 9.1% | 0.3% | 2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 9.1% |
0.3% |
2.2% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses